(2019) Synthesis, molecular docking studies, and absorption, distribution, metabolism, and excretion prediction of novel sulfonamide derivatives as antibacterial agents. Journal of the Chinese Chemical Society. pp. 558-566. ISSN 00094536 (ISSN)
Full text not available from this repository.
Abstract
A series of novel sulfonamide-amide derivatives were synthesized from 3-(2,4 dichlorophenylamino)-3-oxopropane-1-sulfonylchloride and a variety of amines under solvent-free conditions at room temperature. 3-(2,4-dichlorophenylamino)-3-oxopropane-1 sulfonylchloride was synthesized in four steps starting from 2,4-dichloroaniline and chloropropanoic acid in good yield and purity. The synthesized compounds were screened for their in vitro antibacterial activity against Escherichia coli (ATCC 25922) and Staphylococcus aureus (ATCC 29213). Molecular docking of sulfonamide derivatives into S. aureus tyrosyl-tRNA synthetase (TyrRS)-active site was also performed and among these, 5m and 5g tightly fit the active sites that might be inhibitors of TyrRS for further investigations. Also in the silico metabolism profile, drug-like properties and absorption, distribution, metabolism, excretion and toxicity (ADMET) of the title compounds were calculated by the preADMET server. © 2019 The Chemical Society Located in Taipei & Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Item Type: | Article |
---|---|
Keywords: | ADMET antibacterial activity molecular docking solvent-free sulfonamide-amide |
Subjects: | QV Pharmacology |
Divisions: | Faculty of Pharmacy and Pharmaceutical Sciences > Department of Pharmaceutical Biotechnology Faculty of Pharmacy and Pharmaceutical Sciences > گروه شیمی دارویی |
Page Range: | pp. 558-566 |
Journal or Publication Title: | Journal of the Chinese Chemical Society |
Journal Index: | Scopus |
Volume: | 66 |
Number: | 5 |
Identification Number: | https://doi.org/10.1002/jccs.201800207 |
ISSN: | 00094536 (ISSN) |
Depositing User: | Zahra Otroj |
URI: | http://eprints.mui.ac.ir/id/eprint/10806 |
Actions (login required)
View Item |